YP

Yogesh Patidar

Active Director Director DIN 07788683
DIN 07788683 First appointment May 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2017
Shareholding value •••• Premium profile

About Yogesh Patidar

Data last updated:

Yogesh Patidar is a Director at Abrik Remedies Private Limited (since 2017). The company operates in Pharma. Abrik Remedies Private Limited reported revenue of ₹4.43 Cr (FY 2024).

DIN 07788683
Primary Designation Director
Industry Pharma
First Appointment 04 May 2017
Oldest Company Age 9 yrs
Largest company Abrik Remedies Private Limited · ₹4.43 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Abrik Remedies Private Limited U51909MP2017PTC043259
Director04 May 20172017₹4.43 Cr (FY 2024)Active

Board colleagues of Yogesh Patidar

NameDINCompanyDesignation
Jitendra Patidar07887726Abrik Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Abrik Remedies Private Limited
Premium access

Shareholding and investment profile for Yogesh Patidar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Patidar

Yogesh Patidar currently holds 1 directorship: Abrik Remedies Private Limited (Director, since 04 May 2017, revenue ₹4.43 Cr (FY 2024)).

Yogesh Patidar was first appointed on 04 May 2017 as Director at Abrik Remedies Private Limited.

The current boards of Yogesh Patidar's companies include Jitendra Patidar (Abrik Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available